|
Press Releases |
|
 |
|
Thursday, June 19, 2025 |
|
ULVAC Continues Participation in "Lab-in-Fab" Project to Advance Piezoelectric MEMS Technology, Now Entering a New Phase |
ULVAC, Inc. announced that the collaborative development project "Lab-in-Fab," aimed at advancing piezoelectric Micro-Electro-Mechanical Systems (piezoMEMS) *1 technology and in which ULVAC has participated since 2020, is entering a new phase. more info >> |
|
Tuesday, December 6, 2022 |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
Thursday, June 2, 2022 |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
more info >> |
|
Thursday, September 30, 2021 |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
Friday, July 31, 2020 |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
Friday, July 24, 2020 |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
Tuesday, October 22, 2019 |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
Friday, June 28, 2019 |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
Friday, April 5, 2019 |
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
It is with deep regret that the Agency for Science, Technology and Research (A*STAR) announces the passing of Dr Sydney Brenner, Honorary Singapore Citizen, and A*STAR Senior Fellow, early this morning. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Queensland's First Nations businesses forge global trade links
Aug 26, 2025 22:39 HKT/SGT
|
|
|
Resilient Interim Results, Essex Bio-Technology Drives Growth and Innovation
Aug 26, 2025 20:00 HKT/SGT
|
|
|
Kincora Copper: Positive Drilling Results at Two Northern Junee-Narromine Belt Projects
Aug 26, 2025 19:09 HKT/SGT
|
|
|
31 Concept and Bestcomp Group Form Strategic Partnership to Elevate AI-Driven Network Intelligence Across Eurasia
Aug 26, 2025 18:30 HKT/SGT
|
|
|
Focus Graphite Achieves First Aerospace Validation with Lac Knife Graphite in a Successful Hypersonic Rocket Launch
Aug 26, 2025 17:09 HKT/SGT
|
|
|
Shuangdeng Group Listed on the Main Board of the Hong Kong Stock Exchange
Aug 26, 2025 16:39 HKT/SGT
|
|
|
Nissin Foods Announces 2025 Interim Results
Aug 26, 2025 14:15 HKT/SGT
|
|
|
VCREDIT 2025 Interim Results: Driving High-Quality Growth through a Solidified Digital Financial Ecosystem and Strategic Advancement
Aug 26, 2025 13:39 HKT/SGT
|
|
|
TANAKA to Showcase Advanced Semiconductor Materials in its Inaugural Participation at SEMICON India 2025
Aug 26, 2025 13:30 JST
|
|
|
Honda to Hold Official e-Motorsports Event, "Honda Racing eMS 2025"
Aug 26, 2025 13:17 JST
|
|
|
Mitsubishi Corporation Invests in Fullerton Health
Aug 26, 2025 12:54 JST
|
|
|
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI(R) (lecanemab)
Aug 25, 2025 19:30 JST
|
|
|
Shibaura Institute of Technology, Waseda University and Fujitsu develop quantum computer-based robot posture optimization
Aug 25, 2025 18:22 JST
|
|
|
Dida Inc. (02559.HK) Announced 2025 Interim Results, RMB 135.8 Million Adjusted Net Profit
Aug 25, 2025 17:03 HKT/SGT
|
|
|
NEC technology predicts sudden traffic congestion in real time using optical fiber cables
Aug 25, 2025 17:30 JST
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|